Copper cu 64 dotatate injection: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

30 April 2025

  • curprev 05:5605:56, 30 April 2025 Alara E. Dagsali talk contribs 16,238 bytes +16,238 Created page with "{{DrugProjectFormSinglePage |authorTag= Alara Ece Dagsali, M.D. |genericName=copper cu 64 dotatate injection |aOrAn=a |drugClass=somatostatin receptor-positive neuroendocrine tumors (NETs) |indicationType=diagnosis |indication=Detectnet is indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients. |adverseReactions=The following clinically significant adverse r..."